| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Revenue | $23.1M | +201.9% |
| Cost of Revenue | $25.1M | -60.2% |
| Gross Profit | -$2.0M | +96.3% |
| R&D Expense | $124.5M | +40.9% |
| SG&A Expense | $74.3M | -6.0% |
| Operating Income | -$242.7M | -5.4% |
| Interest Expense | $6.8M | +52.3% |
| Pre-tax Income | -$223.9M | -4.3% |
| Income Tax | -$1.4M |
| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $272.9M | +17.1% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $4.6M | +402.3% |
| Inventory | $7.7M | -12.3% |
| Current Assets | $295.0M | -8.7% |
| Total Assets | $527.2M | -6.6% |
| Current Liabilities | $53.7M | -12.0% |
| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$108.6M | -3.8% |
| Capital Expenditures | $76.2M | +23.3% |
| Investing Cash Flow | -$1.4M | +99.0% |
| Financing Cash Flow | $150.7M | -5.5% |
| Free Cash Flow | -$184.8M | -11.0% |
| -119.9% |
| Net Income | -$222.2M | -3.8% |
| EPS (Basic) | -$1.27 | +5.9% |
| EPS (Diluted) | -$1.27 | +8.0% |
| Long-term Debt |
| $170.0M |
| -0.4% |
| Total Liabilities | $277.8M | -8.4% |
| Stockholders' Equity | $246.7M | -4.4% |